Quantitative analysis for Inovio Pharmaceuticals, Inc. (INO) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Sell (36.0) (grade D). 25 signals analyzed (21 differentiated alt-data).
INO stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $1.16 | $1.12 | $1.12 |
| 2026-05-11 | $1.64 | $1.39 | $1.43 |
| 2026-05-21 | $1.34 | $1.22 | $1.33 |
| 2026-06-03 | $1.22 | $1.13 | $1.14 |
| 2026-06-15 | $1.15 | $1.10 | $1.10 |
| 2026-06-26 | $1.12 | $1.08 | $1.10 |
| 2026-07-09 | $1.25 | $1.18 | $1.19 |
| 2026-07-21 | $1.10 | $1.07 | $1.10 |
| 2026-07-31 | $0.68 | $0.62 | $0.68 |
| 2026-08-12 | $0.78 | $0.75 | $0.77 |
| 2026-08-24 | $1.30 | $1.15 | $1.25 |
| 2026-09-03 | $1.44 | $1.33 | $1.36 |
How Inovio Pharmaceuticals, Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| SGMO | Sangamo Therapeutics, Inc. | $66M | — |
| GUTS | Fractyl Health, Inc. Common Stock | $67M | — |
| XTNT | Xtant Medical Holdings, Inc. | $65M | — |
| CBUS | Cibus, Inc. | $65M | — |
View all Health Care stocks by valuation and signals →
Inovio Pharmaceuticals, Inc. (INO) scores Sell (36.0), with every measured dimension at or below 47. The weakest are technicals at 20, competitive moat at 1, across 3 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| analyst consensus | 47 |
| technicals | 20 |
| competitive moat | 1 |
StoQuant analyzes 25 signals (21 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Inovio Pharmaceuticals, Inc. (INO): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/INO"><img src="https://stoquant.com/badge/INO.svg" alt="Inovio Pharmaceuticals, Inc. (INO) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.